Nimesulide: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 1: Line 1:
Sandbox drug2
{{DrugProjectFormSinglePage
|authorTag=<!--Overview-->
|aOrAn=a
|hasBlackBoxWarning=Yes
|adverseReactions=<!--Black Box Warning-->
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>


Sandbox drug2®
* Content


Black Box Warning
<!--Adult Indications and Dosage-->


Adult Indications and Dosage
<!--FDA-Labeled Indications and Dosage (Adult)-->
|fdaLIADAdult======Condition1=====


Pediatric Indications and Dosage
* Dosing Information


Contraindications
:* Dosage


Warnings
=====Condition2=====


Adverse Reactions
* Dosing Information


Drug Interactions
:* Dosage


Use in Specific Populations
=====Condition3=====


Administration and Monitoring
* Dosing Information


IV Compatibility
:* Dosage


Overdosage
=====Condition4=====


Pharmacology
* Dosing Information


Clinical Studies
:* Dosage


How Supplied
<!--Off-Label Use and Dosage (Adult)-->


Images
<!--Guideline-Supported Use (Adult)-->
|offLabelAdultGuideSupport======Condition1=====


Patient Counseling Information
* Developed by:


Precautions with Alcohol
* Class of Recommendation:


Brand Names
* Strength of Evidence:


Look-Alike Drug Names
* Dosing Information


Drug Shortage Status
:* Dosage


Price
=====Condition2=====


For patient information regarding , click [[{{{genericName}}} (patient information)|here]].
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];
<!--Non–Guideline-Supported Use (Adult)-->
|offLabelAdultNoGuideSupport======Condition1=====


Disclaimer
* Dosing Information


WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
:* Dosage


Black Box Warning
=====Condition2=====


ConditionName:
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


See full prescribing information for complete boxed warning.
<!--Pediatric Indications and Dosage-->


ConditionName:
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
|fdaLIADPed======Condition1=====


Content
* Dosing Information


Overview
:* Dosage


Sandbox drug2 is a {{{drugClass}}} that is FDA approved for the treatment of {{{indication}}}. There is a Black Box Warning for this drug as shown here. Common adverse reactions include .
=====Condition2=====


Adult Indications and Dosage
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.


FDA-Labeled Indications and Dosage (Adult)Condition1
<!--Off-Label Use and Dosage (Pediatric)-->
Dosing Information


Dosage
<!--Guideline-Supported Use (Pediatric)-->
|offLabelPedGuideSupport======Condition1=====


Condition2
* Developed by:
Dosing Information


Dosage
* Class of Recommendation:


Condition3
* Strength of Evidence:
Dosing Information


Dosage
* Dosing Information


Condition4
:* Dosage
Dosing Information


Dosage
=====Condition2=====


Off-Label Use and Dosage (Adult)Guideline-Supported UseCondition1
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
Developed by:


Class of Recommendation:
<!--Non–Guideline-Supported Use (Pediatric)-->
|offLabelPedNoGuideSupport======Condition1=====


Strength of Evidence:
* Dosing Information


Dosing Information
:* Dosage


Dosage
=====Condition2=====


Condition2
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


There is limited information regarding Off-Label Guideline-Supported Use of Sandbox drug2 in adult patients.
<!--Contraindications-->
|contraindications=* Condition1


Non–Guideline-Supported Use
<!--Warnings-->
|warnings=* Description


Condition1
====Precautions====
Dosing Information


Dosage
* Description


Condition2
<!--Adverse Reactions-->


There is limited information regarding Off-Label Non–Guideline-Supported Use of Sandbox drug2 in adult patients.
<!--Clinical Trials Experience-->
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.


Pediatric Indications and Dosage
=====Body as a Whole=====


FDA-Labeled Indications and Dosage (Pediatric)Condition1
Dosing Information


Dosage


Condition2


There is limited information regarding FDA-Labeled Use of Sandbox drug2 in pediatric patients.
=====Cardiovascular=====


Off-Label Use and Dosage (Pediatric)


Guideline-Supported UseCondition1
Developed by:


Class of Recommendation:


Strength of Evidence:
=====Digestive=====


Dosing Information


Dosage


Condition2


There is limited information regarding Off-Label Guideline-Supported Use of Sandbox drug2 in pediatric patients.
=====Endocrine=====


Non–Guideline-Supported Use


Condition1
Dosing Information


Dosage


Condition2
=====Hematologic and Lymphatic=====


There is limited information regarding Off-Label Non–Guideline-Supported Use of Sandbox drug2 in pediatric patients.


Contraindications


Condition1


Warnings
=====Metabolic and Nutritional=====


ConditionName:


See full prescribing information for complete boxed warning.


ConditionName:


Content
=====Musculoskeletal=====


Description


Precautions
Description


Adverse ReactionsClinical Trials Experience


There is limited information regarding Clinical Trial Experience of Sandbox drug2 in the drug label.
=====Neurologic=====


Body as a Whole


CardiovascularDigestiveEndocrineHematologic and LymphaticMetabolic and NutritionalMusculoskeletalNeurologicRespiratorySkin and Hypersensitivy ReactionsSpecial SensesUrogenitalMiscellaneousPostmarketing Experience


There is limited information regarding Postmarketing Experience of Sandbox drug2 in the drug label.


Body as a Whole
=====Respiratory=====


CardiovascularDigestiveEndocrineHematologic and LymphaticMetabolic and NutritionalMusculoskeletalNeurologicRespiratorySkin and Hypersensitivy ReactionsSpecial SensesUrogenitalMiscellaneousDrug Interactions
Drug


Description


Use in Specific PopulationsPregnancy


Pregnancy Category (FDA):
=====Skin and Hypersensitivy Reactions=====


Pregnancy Category


Pregnancy Category (AUS):


Australian Drug Evaluation Committee (ADEC) Pregnancy Category


There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Sandbox drug2 in women who are pregnant.
=====Special Senses=====


Labor and Delivery


There is no FDA guidance on use of Sandbox drug2 during labor and delivery.


Nursing Mothers


There is no FDA guidance on the use of Sandbox drug2 with respect to nursing mothers.
=====Urogenital=====


Pediatric Use


There is no FDA guidance on the use of Sandbox drug2 with respect to pediatric patients.


Geriatic Use


There is no FDA guidance on the use of Sandbox drug2 with respect to geriatric patients.
=====Miscellaneous=====


Gender


There is no FDA guidance on the use of Sandbox drug2 with respect to specific gender populations.


Race
<!--Postmarketing Experience-->
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.


There is no FDA guidance on the use of Sandbox drug2 with respect to specific racial populations.
=====Body as a Whole=====


Renal Impairment


There is no FDA guidance on the use of Sandbox drug2 in patients with renal impairment.


Hepatic Impairment
=====Cardiovascular=====


There is no FDA guidance on the use of Sandbox drug2 in patients with hepatic impairment.


Females of Reproductive Potential and Males


There is no FDA guidance on the use of Sandbox drug2 in women of reproductive potentials and males.
=====Digestive=====


Immunocompromised Patients


There is no FDA guidance one the use of Sandbox drug2 in patients who are immunocompromised.


Administration and Monitoring
=====Endocrine=====


Administration
Oral


Intravenous


Monitoring
=====Hematologic and Lymphatic=====


There is limited information regarding Monitoring of Sandbox drug2 in the drug label.


Description


IV Compatibility
=====Metabolic and Nutritional=====


There is limited information regarding IV Compatibility of Sandbox drug2 in the drug label.


Overdosage


Acute OverdoseSigns and Symptoms
=====Musculoskeletal=====
Description


Management
Description


Chronic Overdose


There is limited information regarding Chronic Overdose of Sandbox drug2 in the drug label.
=====Neurologic=====


Pharmacology


Mechanism of Action


Structure
=====Respiratory=====


File:Sandbox drug201.png


This image is provided by the National Library of Medicine.


Pharmacodynamics
=====Skin and Hypersensitivy Reactions=====


There is limited information regarding Pharmacodynamics of Sandbox drug2 in the drug label.


Pharmacokinetics


There is limited information regarding Pharmacokinetics of Sandbox drug2 in the drug label.
=====Special Senses=====


Nonclinical Toxicology


There is limited information regarding Nonclinical Toxicology of Sandbox drug2 in the drug label.


Clinical Studies
=====Urogenital=====


There is limited information regarding Clinical Studies of Sandbox drug2 in the drug label.


How Supplied


Images
=====Miscellaneous=====


Drug Images


Drug Name:
Ingredient(s):
Imprint:
Dosage: {{{dosageValue}}} {{{dosageUnit}}}
Color(s):
Shape:
Size (mm):
Score:
NDC:


Drug Label Author:
<!--Drug Interactions-->
|drugInteractions=* Drug
:* Description


This pill image is provided by the National Library of Medicine's PillBox.
<!--Use in Specific Populations-->
|useInPregnancyFDA=* '''Pregnancy Category'''
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''


Package and Label Display Panel
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
|useInNursing=There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
|useInGender=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
|useInRace=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
|useInRenalImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
|useInHepaticImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.


File:Sandbox drug211.png
<!--Administration and Monitoring-->
|administration=* Oral


This image of the FDA label is provided by the National Library of Medicine.
* Intravenous
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.


Patient Counseling Information
* Description


There is limited information regarding Patient Counseling Information of Sandbox drug2 in the drug label.
<!--IV Compatibility-->
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.


Precautions with Alcohol
<!--Overdosage-->
|overdose====Acute Overdose===


Alcohol-Sandbox drug2 interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
====Signs and Symptoms====


Brand Names
* Description
®[1]


Look-Alike Drug Names
====Management====
A® — B®[2]


Drug Shortage StatusPrice
* Description


References
===Chronic Overdose===


The contents of this FDA label are provided by the National Library of Medicine.
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.


Jump up↑ You must specify title = and url = when using {{cite web}}..
<!--Pharmacology-->
 
<!--Drug box 2-->
|drugBox=<!--Mechanism of Action-->
|mechAction=*
 
<!--Structure-->
|structure=*
 
: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
 
<!--Pharmacodynamics-->
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
 
<!--Pharmacokinetics-->
|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
 
<!--Nonclinical Toxicology-->
|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
 
<!--Clinical Studies-->
|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
 
<!--How Supplied-->
|howSupplied=*
|packLabel=<!--Patient Counseling Information-->
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
 
<!--Precautions with Alcohol-->
|alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
 
<!--Brand Names-->
|brandNames=* ®<ref>{{Cite web | title = | url = }}</ref>
 
<!--Look-Alike Drug Names-->
|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
 
<!--Drug Shortage Status-->
|drugShortage=
}}
{{PillImage
|fileName=No image.jpg
}}
{{LabelImage
|fileName={{PAGENAME}}11.png
}}
{{LabelImage
|fileName={{PAGENAME}}11.png
}}
<!--Pill Image-->
 
 
 
<!--Label Display Image-->
 
 
 
 
 
<!--Category-->
 
[[Category:Drug]]

Revision as of 19:49, 9 January 2015

Nimesulide
Black Box Warning
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Black Box Warning

ConditionName:
See full prescribing information for complete Boxed Warning.
ConditionName:
  • Content

Overview

Nimesulide is a {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. There is a Black Box Warning for this drug as shown here. Common adverse reactions include .

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Condition1
  • Dosing Information
  • Dosage
Condition2
  • Dosing Information
  • Dosage
Condition3
  • Dosing Information
  • Dosage
Condition4
  • Dosing Information
  • Dosage

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Condition1
  • Developed by:
  • Class of Recommendation:
  • Strength of Evidence:
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Nimesulide in adult patients.

Non–Guideline-Supported Use

Condition1
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Nimesulide in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Condition1
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding FDA-Labeled Use of Nimesulide in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Condition1
  • Developed by:
  • Class of Recommendation:
  • Strength of Evidence:
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Nimesulide in pediatric patients.

Non–Guideline-Supported Use

Condition1
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Nimesulide in pediatric patients.

Contraindications

  • Condition1

Warnings

ConditionName:
See full prescribing information for complete Boxed Warning.
ConditionName:
  • Content
  • Description

Precautions

  • Description

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Nimesulide in the drug label.

Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Nimesulide in the drug label.

Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous

Drug Interactions

  • Drug
  • Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Pregnancy Category


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Nimesulide in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Nimesulide during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Nimesulide with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Nimesulide with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Nimesulide with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Nimesulide with respect to specific gender populations.

Race

There is no FDA guidance on the use of Nimesulide with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Nimesulide in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Nimesulide in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Nimesulide in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Nimesulide in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Oral
  • Intravenous

Monitoring

There is limited information regarding Monitoring of Nimesulide in the drug label.

  • Description

IV Compatibility

There is limited information regarding IV Compatibility of Nimesulide in the drug label.

Overdosage

Acute Overdose

Signs and Symptoms

  • Description

Management

  • Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Nimesulide in the drug label.

Pharmacology

There is limited information regarding Nimesulide Pharmacology in the drug label.

Mechanism of Action

Structure

File:Nimesulide01.png
This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Nimesulide in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Nimesulide in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Nimesulide in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Nimesulide in the drug label.

How Supplied

Storage

There is limited information regarding Nimesulide Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Nimesulide |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Nimesulide |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Nimesulide in the drug label.

Precautions with Alcohol

  • Alcohol-Nimesulide interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Look-Alike Drug Names

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ Empty citation (help)
  2. ↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject: 

 |Page Name=Nimesulide
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject: 

 |Label Page=Nimesulide
 |Label Name=Nimesulide11.png

}}

{{#subobject: 

 |Label Page=Nimesulide
 |Label Name=Nimesulide11.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Nimesulide&oldid=1053279"